Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2017

Open Access 01-12-2017 | Study protocol

The ACHRU-CPP versus usual care for older adults with type-2 diabetes and multiple chronic conditions and their family caregivers: study protocol for a randomized controlled trial

Authors: Maureen Markle-Reid, Jenny Ploeg, Kimberly D. Fraser, Kathryn Ann Fisher, Noori Akhtar-Danesh, Amy Bartholomew, Amiram Gafni, Andrea Gruneir, Sandra P. Hirst, Sharon Kaasalainen, Caralyn Kelly Stradiotto, John Miklavcic, Carlos Rojas-Fernandez, Cheryl A. Sadowski, Lehana Thabane, Jean A. C. Triscott, Ross Upshur

Published in: Trials | Issue 1/2017

Login to get access

Abstract

Background

Many community-based self-management programs have been developed for older adults with type-2 diabetes mellitus (T2DM), bolstered by evidence from randomized controlled trials (RCTs) that T2DM can be prevented and managed through lifestyle modifications. However, the evidence for their effectiveness is contradictory and weakened by reliance on single-group designs and/or small samples. Additionally, older adults with multiple chronic conditions (MCC) are often excluded because of recruiting and retention challenges. This paper presents a protocol for a two-armed, multisite, pragmatic, mixed-methods RCT examining the effectiveness and implementation of the Aging, Community and Health Research Unit-Community Partnership Program (ACHRU-CPP), a new 6-month interprofessional, nurse-led program to promote self-management in older adults (aged 65 years or older) with T2DM and MCC and support their caregivers (including family and friends).

Methods/design

The study will enroll 160 participants in two Canadian provinces, Ontario and Alberta. Participants will be randomly assigned to the control (usual care) or program study arm. The program will be delivered by registered nurses (RNs) and registered dietitians (RDs) from participating diabetes education centers (Ontario) or primary care networks (Alberta) and program coordinators from partnering community-based organizations. The 6-month program includes three in-home visits, monthly group sessions, monthly team meetings for providers, and nurse-led care coordination. The primary outcome is the change in physical functioning as measured by the Physical Component Summary (PCS-12) score from the short form-12v2 health survey (SF-12). Secondary client outcomes include changes in mental functioning, depressive symptoms, anxiety, and self-efficacy. Caregiver outcomes include health-related quality of life and depressive symptoms. The study includes a comparison of health care service costs for the intervention and control groups, and a subgroup analysis to determine which clients benefit the most from the program. Descriptive and qualitative data will be collected to examine implementation of the program and effects on interprofessional/team collaboration.

Discussion

This study will provide evidence of the effectiveness of a community-based self-management program for a complex target population. By studying both implementation and effectiveness, we hope to improve the uptake of the program within the existing community-based structures, and reduce the research-to-practice gap.

Trial registration

ClinicalTrials.gov, Identifier: NCT02158741. Registered on 3 June 2014.
Appendix
Available only for authorised users
Literature
1.
2.
3.
4.
Yoon U, Kwok LL, Magkidis A. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials. Metabolism. 2013;62:303–14.CrossRefPubMed
5.
Kirkman M, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS, Pratley RE, Swift C. Diabetes in older adults: a consensus report. J Am Geriatr Soc. 2012;60:2342–56.CrossRefPubMedPubMedCentral
6.
7.
Sakharova OV, Inzucchi SE. Treatment of diabetes in the elderly. Addressing its complexities in this high-risk group. Postgrad Med. 2005;118:19–26.CrossRefPubMed
8.
Druss BG, Marcus SC, Olfson M, Tanielian T, Elinson L, Pincus HA. Comparing the national economic burden of five chronic conditions. Health Aff. 2001;20:233–41.CrossRef
9.
Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162:2269–76.CrossRefPubMed
10.
11.
Brown AF, Mangione CF, Saliba D, California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51 Suppl:S265–80.
12.
Willi C, Boderman P, Chali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. J Am Med Assoc. 2007;298:2654–64.CrossRef
13.
Simpson RW, Tuomilehto J, Lindstrom J, Shaw JE, Zimmet P. Prevention of type 2 diabetes mellitus. In: Defronzo RA, Ferrannini E, Keen H, Zimmet P, editors. International textbook of diabetes mellitus. 3rd ed. Chichester: Wiley; 2004. p. 1899–910.
14.
Manson JE, Rimm EB, Stampfer MJ, Coldite GA. Physical inactivity and incidence of non-insulin dependent diabetes mellitus in women. Lancet. 1991;38:774–8.CrossRef
15.
16.
Hamman RF. Genetic and environmental determinants of noninsulin-dependent diabetes mellitus (NIDDM). Diabetes Met Rev. 1992;8:287–338.CrossRef
17.
Ducat L, Philipson LH, Anderson BJ. The mental health comorbidities of diabetes. J Am Med Assoc. 2014;312(7):691–2.
18.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.CrossRefPubMed
19.
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.CrossRefPubMed
20.
Tuomilehto J, Schwarz P, Lindstrom J. Long-term benefits from lifestyle interventions for type 2 diabetes prevention. Diabetes Care. 2011;34 Suppl 2:S2110–214.
21.
Knowler WC, Fowler SE, Hamman RF. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–86.CrossRefPubMed
22.
Espeland MA, Rejeske WJ, West DS, Bray GA, Clark JM, Peters AL, Chen H, Johnson KC, Horton ES, Hazuda HP. Intensive weight loss intervention in older individuals: results from the action for health in diabetes type 2 diabetes mellitus trial. J Am Geriatr Soc. 2013;61:913–22.CrossRef
23.
Usitupa M, Tuomilehto J, Puska P. Are we really active in the prevention of obesity and type 2 diabetes at the community level? Nutr Metab Cardiovasc Dis. 2011;21:380–9.CrossRef
24.
Busetto L, Ger Luijkx K, Elissen AMJ, Vrijhoef HJM. Intervention types and outcomes of integrated care for diabetes mellitus type 2: a systematic review. J Eval Clin Pract. 2016;22:299–310.CrossRefPubMed
25.
Kramer MK, Kriska AM, Venditti EM, Miller RG, Brooks MM, Burke LE, Siminerio LM, Solano FX, Orchard TJ. Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery. Am J Prev Med. 2009;37:505–11.CrossRefPubMed
26.
Steinsbekk A, Rygg LO, Lisulo M, Rise MB, Fretheim A. Group-based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis. BMC Health Serv Res. 2012. doi:10.​1186/​1472-6963-12-213.
27.
Kulzer B, Hermanns N, Krichbaum M, Gorges D, Haak T. Pimäre prevention des typ-2-diabetes durch lebensstilmodifikation: ergebnisse des präventionsprogramms PRAEDIAS. Diabetologe. 2014. doi:10.​1007/​s11428-013-1182-4.
28.
Vojta D, Koehler TB, Longjohn M, Lever JA, Caputo NF. A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program. Am J Prev Med. 2013;44(4 Suppl 4):S301–6.CrossRefPubMed
29.
Beverly EA, Fitzgerald S, Sitnikov L, Ganda OP, Caballero AE, Weinger K. Do older adults aged 60–75 years benefit from diabetes behavioral interventions? Diabetes Care. 2013;36:1501–6.CrossRefPubMedPubMedCentral
30.
Krukowski RA, Pope RA, Love S, Lensing S, Felix HC, Prewitt TE, West D. Examination of costs for a lay health educator-delivered translation of the Diabetes Prevention Program in senior centers. Prev Med. 2013;57:400–2.CrossRefPubMed
31.
Pariser G, Hager K, Gillette P, Golemboski K, Jackson K. Active steps for diabetes a community-campus partnership addressing frailty and diabetes. Diabetes Educ. 2014;40:60–7.CrossRefPubMed
32.
33.
Ali MK, Echouffo-Tcheugui JB, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Heal Aff. 2012;31:67–75.CrossRef
34.
Ruggiero L, Castillo A, Quinn L, Hockwert M. Translation of the Diabetes Prevention Program’s lifestyle intervention: role of community health workers. Curr Diab Rep. 2012;12:127–37.CrossRefPubMed
35.
Katula KA, Vitolins MZ, Morgan TM, Lawlor MS, Blackwell CS, Isom SP, Pedley CF, Goff Jr DC. The Healthy Living Partnerships to Prevent Diabetes Study 2-year outcomes of a randomized controlled trial. Am J Prev Med. 2013;44:S324–32.CrossRefPubMedPubMedCentral
36.
Cruz-Jentoft AJ, Montero-Errasquin M, Sanches-Castellano B, Sanchez-Garcia E. Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus. J Am Geriatr Soc. 2013;61:734–8.CrossRefPubMed
37.
Okereke OI, Kang JH, Cook NR, Gaziano JM, Manson JE, Buring JE, Grodstin F. Type 2 diabetes mellitus and cognitive decline in two large cohorts of community-dwelling older adults. J Am Geriatr Soc. 2008;56:1028–36.CrossRefPubMed
38.
39.
Markle-Reid M, Browne G, Gafni A, Roberts J, Weir R, Thabane L, Miles M, Vaitonis V, Hecimovich C, Baxter P, Henderson S. A cross-sectional study of the prevalence, correlates, and costs of falls in older home care clients “at risk” for falling. Can J Aging. 2010;29:119–37.CrossRefPubMed
40.
Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012;142(Suppl):S8–21.CrossRefPubMed
41.
Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin J, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleža-Jerić K, Laupacis A, Moher D. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.CrossRefPubMedPubMedCentral
42.
Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50:217–26.CrossRefPubMedPubMedCentral
43.
Markle-Reid M, Ploeg J, Fisher K, Reimer H, Kaasalainen S, Gafni A, Gruneir A, Kirkconnell R, Marzouk S, Akhtar-Danesh N, Thabane L, Rojas-Fernandez C, Upshur R. The Aging, Community and Health Research Unit – Community Partnership Program for older adults with type 2 diabetes and multiple chronic conditions: a feasibility study. Pilot Feasibility Stud. 2016. doi:10.​1186/​s40814-016-0063-1.PubMedPubMedCentral
44.
Curry L, Nunez-Smith M. Mixed methods in health sciences research: a practical primer. Los Angeles: Sage; 2015.
45.
46.
47.
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009. doi:10.​1186/​1748-5908-4-50.PubMedPubMedCentral
48.
Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23:433–41.CrossRefPubMed
49.
50.
51.
52.
53.
Bandura A. Exercise of personal and collective efficacy in changing societies. In: Bandura A, editor. Self-efficacy in changing societies. Cambridge: Cambridge University Press; 1995. p. 1–45.CrossRef
54.
Bandura A. Self-efficacy: toward a unifying theory of behavioural change. Psychol Rev. 1977;84:191–215.CrossRefPubMed
55.
Zwarenstein M, Treweek S, Gagnier J, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D, for the CONSORT and Pragmatic Trials in Healthcare (Practice) groups. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390.CrossRefPubMedPubMedCentral
56.
Maruish ME, editor. SF-12 user’s manual 2012: user’s manual for the SF-12v2 Health Survey. 3rd ed. Lincoln: QualityMetric Incorporated; 2012.
57.
Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582–92.PubMed
58.
Ware JE, Kosinski MK. A 12 item short form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.CrossRefPubMed
59.
60.
Wyatt KD, Stuart LM, Brito JP, Carranza Leon B, Domecq JP, Prutsky GJ, Egginton JS, Calvin AD, Shah ND, Murad MH, Montori VM. Out of context: clinical practice guidelines and patients with multiple chronic conditions: a systematic review. Med Care. 2014;52 Suppl 3:S92–100.CrossRefPubMed
61.
Vilagut G, Forero CG, Pinto-Meza A, Haro JM, de Graaf R, Bruffaerts R, Kovess V, de Girolamo G, Matschinger H, Ferrere M, Alonso J, ESEMeD Investigators. The mental component of the short-form 12 health survey (SF-12) as a measure of depressive disorders in the general population: results with three alternative scoring methods. Value Health. 2013;16:564–73.CrossRefPubMed
62.
Boey KW. Cross-validation of a short-form of the CES-D in Chinese elderly. Int J Geriatr Psychiatry. 1999;14:608–17.CrossRefPubMed
63.
Irwin M, Artin KH, Oxman MD. Screening for depression in the older adult: criterion validity of the 10-item Centre for Epidemiological Studies Depression Scale (CES-D). Arch Intern Med. 1999;159(15):1701–4.CrossRefPubMed
64.
Andresen EM, Malgren JA, Carter WB, Patrick DC. Screening for depression in well older adults: evaluation of a short-form of the CES-D (Center for Epidemiological Studies in Depression Scale). Am J Prev Med. 1994;10:77–84.PubMed
65.
66.
Zou JB, Dear BF, Titov N, Loria CN, Johnston L, Spence J, Knight RG, Anderson T, Sachdev P. Brief Internet-delivered cognitive behavioral therapy for anxiety in older adults: a feasibility trial. J Anxiety Disord. 2012;26:650–5.CrossRefPubMed
67.
Kroenke K, Spitzer RL, Williams JB, Monohan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146:317–25.CrossRefPubMed
68.
Lowe B, Decker O, Muller S, Brahler E, Schellberg D, Herzog W, Herzberg PY. Validation and standardization of the Generalized Anxiety Disorder screener (GAD-7) in the general population. Med Care. 2008;46:266–74.CrossRefPubMed
69.
Kroenke K, Spitzer RL, Williams JB, Lowe B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry. 2010;32:345–59.CrossRefPubMed
70.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.CrossRefPubMed
71.
Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943–50.CrossRefPubMed
72.
Majumdar SR, Johnson JA, Bowker SL, Booth GL, Dolovich L, Ghali WA, Harris SB, Hux J, Holbrook A, Lee HN, Toth EL, Yale JF. A Canadian consensus for the standardized evaluation of quality improvement interventions in type-2 diabetes. Can J Diabetes. 2005;29:200–29.
73.
Thornton M, Travis SS. Analysis of the reliability of the Modified Caregiver Strain Index. J Gerontol Soc Sci. 2003;58B:S127–32.CrossRef
74.
Al-Khawalden OA, Al-Hassan MA, Forelicher ES. Self-efficacy, self-management, and glycemic control in adults with type 2 diabetes mellitus. J Diabetes Complications. 2012;26:10–6.CrossRef
75.
Didarloo AR, Shojaeizadeh D, Gharaaghaji Asl R, Habibzadeh H, Niknami S, Pourali R. Predictors of self-management behaviour among Iranian women with type 2 diabetes: application of the theory of reasoned action along with self-efficacy (ETRA). Iran Red Crescent Med J. 2012;14:86–95.PubMedPubMedCentral
76.
Fisher L, Hessler D, Masharani U, Strycker L. Impact of baseline patient characteristics on interventions to reduce diabetes distress: the role of personal conscientiousness and diabetes self-efficacy. Diabet Med. 2014;31:739–46.CrossRefPubMedPubMedCentral
77.
Gatt S, Sammut R. An exploratory study of predictors of self-care behaviour in persons with type 2 diabetes. Int J Nurs Stud. 2008;45:1525–33.CrossRefPubMed
78.
Huang M, Zhao R, Jiang X. Self management behaviour in patients with type 2 diabetes: a cross-sectional survey in western urban China. PLoS One. 2014;9:1–7.CrossRef
79.
Chen SR, Chien YP, Kang CM, Jeng C, Chang WY. Comparing self-efficacy and self-care behaviours between outpatients with comorbid schizophrenia and type 2 diabetes and outpatients with only type 2 diabetes. J Psychiatr Ment Health Nurs. 2014;21:414–22.CrossRefPubMed
80.
Wu SF, Huang YC, Lee MC, Wang TJ, Tung HH, Wu MP. Self-efficacy, self-care behaviour, anxiety, and depression in Taiwanese with type 2 diabetes: a cross-sectional survey. Nurs Health Sci. 2013;15:213–9.CrossRefPubMed
81.
82.
Anderson NR, West MA. Measuring climate for work group innovation: development and validation of the team climate inventory. J Organ Behav. 1998;19:235–58.CrossRef
83.
Beaulieu M, Dragieva N, Del Grande C, Dawson J, Haggerty JL, Barnsley J, Hogg WE, Tousignant P, West MA. The Team Climate Inventory as a measure of primary care teams’ processes: validation of the French version. Healthc Policy. 2014;9:40–54.PubMedPubMedCentral
84.
85.
Thabane L, Mbuagbaw L, Zhang S, Samaan Z, Marcucci M, Ye C, Thabane M, Giangregorio L, Dennis B, Kosa D, Borg Debono V, Dillenburg R, Fruci V, Bawor M, Lee J, Wells G, Goldsmith CH. A tutorial on sensitivity analysis in clinical trials: the what, why, when and how. BMC Med Res Methodol. 2013;13:92. doi:10.​1186/​1471-2288-13-92.CrossRefPubMedPubMedCentral
86.
Markle-Reid M, Brown G, Weir R, Gafni A, Roberts J, Henderson SR. The effectiveness and efficiency of home-based nursing health promotion for older people: a review of the literature. Med Care Res Rev. 2006;63:531–69.CrossRefPubMed
87.
Markle-Reid M, Browne G, Gafni A, Roberts J, Weir R, Thabane L, Miles M, Vaitonis V, Hecimovich C, Baxter P, Henderson S. The effects and costs of a multifactorial and interdisciplinary team approach to falls prevention for older home care clients ‘at risk’ for falling: a randomized controlled trial. Can J Aging. 2010;29:139–61.CrossRefPubMed
88.
Stuck AE, Minder CE, Peter-Wuest I, Gillmann G, Egli C, Kesslering A, Leu RE, Beck JC. A randomized trial of in-home visits for disability prevention in community-dwelling older people at low and high risk for nursing home admission. Arch Intern Med. 2000;160:977–86.CrossRefPubMed
89.
Drummond MF, Sculpher JJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.
90.
Markle-Reid M, Gafni A, Ploeg J, Fisher K, Ark P, Miklavcic J. Health and social service utilization costing manual. Technical Paper Series, No. 1. Hamilton: Aging, Community and Health Research Unit, McMaster University; 2016.
91.
Browne G, Roberts J, Gafni A, Byrne C, Weir R, Majumdar B, Watt S. Economic evaluations of community-based care: lessons from twelve studies in Ontario. J Eval Clin Pract. 1999;5:367–85.CrossRefPubMed
92.
Browne G, Roberts J, Byrne C, Gafni A, Weir R, Majumdar B. The costs and effects of addressing the needs of vulnerable populations: results of 10 years of research. Can J Nur Res. 2001;33:65–76.
93.
Guerriere DN, Ungar WJ, Corey M, Croxford R, Tranmer JE, Tullis E, Coyte PC. Evaluation of the ambulatory and home care record: agreement between self-reports and administrative data. Int J Technol Assess Health Care. 2006;22:203–10.CrossRefPubMed
94.
Harris R, Dyson E. Recruitment of frail older people to research: lessons learnt through experience. J Adv Nurs. 2001;36(5):643–6651.CrossRefPubMed
95.
Bowsher J, Bramlett M, Burnside IM, Gueldner SH. Methodological considerations in the study of frail elderly people. J Adv Nurs. 1993;18:873–9.CrossRefPubMed
96.
Davis LL, Broome ME, Cox RP. Maximizing retention in community-based clinical trials. J Nurs Scholarsh. 2002;34:47–53.CrossRefPubMed
97.
Sidani S, Epstein DR, Moritz P. An alternative paradigm for clinical nursing research: an exemplar. Res Nurs Health. 2003;26:244–55.CrossRefPubMed
98.
Whittemore R. How can nursing intervention research reduce the research-practice gap? Can J Nurs Res. 2009;41:7–15.PubMed
99.
Metadata
Title
The ACHRU-CPP versus usual care for older adults with type-2 diabetes and multiple chronic conditions and their family caregivers: study protocol for a randomized controlled trial
Authors
Maureen Markle-Reid
Jenny Ploeg
Kimberly D. Fraser
Kathryn Ann Fisher
Noori Akhtar-Danesh
Amy Bartholomew
Amiram Gafni
Andrea Gruneir
Sandra P. Hirst
Sharon Kaasalainen
Caralyn Kelly Stradiotto
John Miklavcic
Carlos Rojas-Fernandez
Cheryl A. Sadowski
Lehana Thabane
Jean A. C. Triscott
Ross Upshur
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Trials / Issue 1/2017
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-017-1795-9

Other articles of this Issue 1/2017

Trials 1/2017 Go to the issue

Review

A framework for the design, conduct and interpretation of randomised controlled trials in the presence of treatment changes

Study protocol

PANSAID – PAracetamol and NSAID in combination: study protocol for a randomised trial

Study protocol

The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial

Study protocol

Repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depression (TRMD) Veteran patients: study protocol for a randomized controlled trial

Research

Investigating the effect of independent, blinded digital image assessment on the STOP GAP trial

Study protocol

Changing the default for tobacco-cessation treatment in an inpatient setting: study protocol of a randomized controlled trial